Literature DB >> 18266093

Impact of a genetic diagnosis of a mitochondrial disorder 5-17 years after the death of an affected child.

A C Sexton1, M Sahhar, D R Thorburn, S A Metcalfe.   

Abstract

This study used in-depth interviews to explore the experiences of parents who were re-contacted with new genetic results many years after the death of a child with a mitochondrial disorder. At the time of their child's illness, parents had consented to a tissue sample being taken to help with diagnosis of a suspected mitochondrial disorder, and subsequently further DNA testing identified the genetic cause. Parents did not express negative feelings about being re-contacted with new information, and hoped that continuing research might help other families. Positive aspects included relief from feelings of guilt over the cause of the child's disorder, and having accurate genetic information available for surviving children. Difficult emotional and psychosocial implications included contradictions to previous beliefs about inheritance, deciding how and when to communicate information to surviving children, and coping with new fears for the mother's health if a gene located in the mitochondrial DNA was identified. In half of the families the new results significantly altered the parents' understanding of the inheritance pattern. This study highlights the impact of new genetic information offered after a delay of several years, which has the potential to re-open feelings of grief and uncertainty and can present a new inheritance scenario for which research participants or their families are unprepared. Health professionals involved in conveying genetic research results can help to support families through this process.

Entities:  

Mesh:

Year:  2008        PMID: 18266093     DOI: 10.1007/s10897-007-9145-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  27 in total

1.  Taking a narrative approach to grief research: finding meaning in stories.

Authors:  Kathleen R Gilbert
Journal:  Death Stud       Date:  2002-04

2.  Facilitating family communication about predictive genetic testing: probands' perceptions.

Authors:  Clara L Gaff; Veronica Collins; Tiffany Symes; Jane Halliday
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

3.  When you care enough to do your very best: genetic counselor experiences of compassion fatigue.

Authors:  Lacey G Benoit; Patricia McCarthy Veach; Bonnie S LeRoy
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

4.  Does research into sensitive areas do harm? Experiences of research participation after a child's diagnosis with Ewing's sarcoma.

Authors:  Debbie A Scott; Patricia C Valery; Frances M Boyle; Christopher J Bain
Journal:  Med J Aust       Date:  2002-11-04       Impact factor: 7.738

5.  The duty to recontact: attitudes of genetics service providers.

Authors:  J L Fitzpatrick; C Hahn; T Costa; M J Huggins
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

6.  Life is never the same: childhood cancer narratives.

Authors:  R L Woodgate
Journal:  Eur J Cancer Care (Engl)       Date:  2006-03       Impact factor: 2.520

7.  The emergence of an ethical duty to disclose genetic research results: international perspectives.

Authors:  Bartha Maria Knoppers; Yann Joly; Jacques Simard; Francine Durocher
Journal:  Eur J Hum Genet       Date:  2006-07-26       Impact factor: 4.246

8.  Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.

Authors:  T Bourgeron; P Rustin; D Chretien; M Birch-Machin; M Bourgeois; E Viegas-Péquignot; A Munnich; A Rötig
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

9.  Bereaved parents' experience of research participation.

Authors:  Kari Dyregrov
Journal:  Soc Sci Med       Date:  2004-01       Impact factor: 4.634

10.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

View more
  6 in total

1.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

2.  Recontacting or not recontacting? A survey of current practices in clinical genetics centres in Europe.

Authors:  Fabio Sirchia; Daniele Carrieri; Sandi Dheensa; Caroline Benjamin; Hülya Kayserili; Christophe Cordier; Carla G van El; Peter D Turnpenny; Bela Melegh; Álvaro Mendes; Tanya F Halbersma-Konings; Irene M van Langen; Anneke M Lucassen; Angus J Clarke; Francesca Forzano; Susan E Kelly
Journal:  Eur J Hum Genet       Date:  2018-04-23       Impact factor: 4.246

3.  Recontact in clinical practice: a survey of clinical genetics services in the United Kingdom.

Authors:  Daniele Carrieri; Anneke M Lucassen; Angus J Clarke; Sandi Dheensa; Shane Doheny; Peter D Turnpenny; Susan E Kelly
Journal:  Genet Med       Date:  2016-02-18       Impact factor: 8.822

Review 4.  Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.

Authors:  Ellen Otten; Mirjam Plantinga; Erwin Birnie; Marian A Verkerk; Anneke M Lucassen; Adelita V Ranchor; Irene M Van Langen
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

Review 5.  Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes.

Authors:  Eleanor G Seaby; Heidi L Rehm; Anne O'Donnell-Luria
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

6.  Stakeholders' perspectives on the post-mortem use of genetic and health-related data for research: a systematic review.

Authors:  Marieke A R Bak; M Corrette Ploem; Hakan Ateşyürek; Marieke T Blom; Hanno L Tan; Dick L Willems
Journal:  Eur J Hum Genet       Date:  2019-09-16       Impact factor: 4.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.